| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 161.845.033 $ | 100,03 | 7.757.973 | |||||||
| Alkermes Plc | Alkermes PLC | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 7.244.993 $ | 4,48 | 171.723 | |
| Kymera Therapeutics Inc | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 6.851.819 $ | 4,23 | 84.154 | |
| Celcuity Inc | Celcuity, Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 6.337.446 $ | 3,92 | 47.693 | |
| Mirum Pharmaceuticals Inc | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 6.313.199 $ | 3,90 | 62.199 | |
| Spyre Therapeutics Inc | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 5.950.413 $ | 3,68 | 80.958 | |
| Cg Oncology Inc | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 5.421.223 $ | 3,35 | 87.032 | |
| Apogee Therapeutics Inc | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 4.741.285 $ | 2,93 | 57.722 | |
| Xenon Pharmaceuticals Inc | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 4.692.879 $ | 2,90 | 85.746 | |
| Travere Therapeutics Inc | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 4.484.506 $ | 2,77 | 95.051 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 4.263.485 $ | 2,64 | 45.839 | |
| Newamsterdam Pharma Co Nv | Newamsterdam Pharma Co. NV | EC | N62509109 | Long | Börsenkurs (Stufe 1) | 3.991.552 $ | 2,47 | 118.514 | |
| Viking Therapeutics Inc | Viking Therapeutics, Inc. | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 3.899.596 $ | 2,41 | 119.108 | |
| Crinetics Pharmaceuticals Inc | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 3.835.561 $ | 2,37 | 107.892 | |
| Acadia Pharmaceuticals Inc | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 3.806.528 $ | 2,35 | 175.740 | |
| Edgewise Therapeutics Inc | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 3.777.276 $ | 2,33 | 110.576 | |
| Denali Therapeutics Inc | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 3.439.346 $ | 2,13 | 163.467 | |
| Oruka Therapeutics Inc | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 2.920.413 $ | 1,81 | 49.896 | |
| Structure Therapeutics Inc | Structure Therapeutics, Inc. | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 2.872.607 $ | 1,78 | 73.020 | |
| Disc Medicine Inc | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 2.736.466 $ | 1,69 | 39.334 | |
| Ideaya Biosciences Inc | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 2.667.624 $ | 1,65 | 90.520 | |
| Vera Therapeutics Inc | Vera Therapeutics, Inc. | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 2.612.567 $ | 1,61 | 73.552 | |
| Tarsus Pharmaceuticals Inc | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 2.605.878 $ | 1,61 | 43.870 | |
| Relay Therapeutics Inc | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 2.588.347 $ | 1,60 | 184.224 | |
| Mineralys Therapeutics Inc | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 2.569.707 $ | 1,59 | 81.578 | |
| Celldex Therapeutics Inc | Celldex Therapeutics, Inc. | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 2.156.569 $ | 1,33 | 68.615 | |
| Zai Lab Ltd | Zai Lab, Ltd. | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 2.034.898 $ | 1,26 | 115.031 | |
| Pharvaris Nv | Pharvaris NV | EC | N69605108 | Long | Börsenkurs (Stufe 1) | 1.991.344 $ | 1,23 | 66.026 | |
| Sionna Therapeutics Inc | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 1.985.949 $ | 1,23 | 46.379 | |
| Rapport Therapeutics Inc | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 1.945.928 $ | 1,20 | 49.264 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 1.933.927 $ | 1,20 | 108.222 | |
| Lakefront Biotherapeutics Nv | Lakefront Biotherapeutics NV | EC | 36315X101 | Long | Börsenkurs (Stufe 1) | 1.926.241 $ | 1,19 | 67.945 | |
| Tyra Biosciences Inc | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 1.854.556 $ | 1,15 | 55.509 | |
| Novavax Inc | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 1.842.401 $ | 1,14 | 167.949 | |
| Stoke Therapeutics Inc | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 1.819.764 $ | 1,12 | 58.873 | |
| Agios Pharmaceuticals Inc | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 1.775.525 $ | 1,10 | 60.392 | |
| Vericel Corp | Vericel Corp. | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 1.743.459 $ | 1,08 | 52.309 | |
| Nuvation Bio Inc | Nuvation Bio, Inc. | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 1.707.703 $ | 1,06 | 357.260 | |
| Palvella Therapeutics Inc | Palvella Therapeutics, Inc. | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 1.669.812 $ | 1,03 | 14.096 | |
| Taysha Gene Therapies Inc | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 1.657.383 $ | 1,02 | 282.348 | |
| Amylyx Pharmaceuticals Inc | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 1.634.939 $ | 1,01 | 113.933 | |
| Immatics Nv | Immatics NV | EC | N44445109 | Long | Börsenkurs (Stufe 1) | 1.590.567 $ | 0,98 | 138.190 | |
| Immunocore Holdings Plc | Immunocore Holdings PLC | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 1.509.618 $ | 0,93 | 52.254 | |
| Mbx Biosciences Inc | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 1.456.620 $ | 0,90 | 46.286 | |
| Bicara Therapeutics Inc | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 1.420.558 $ | 0,88 | 65.313 | |
| Moonlake Immunotherapeutics | MoonLake Immunotherapeutics | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 1.418.054 $ | 0,88 | 73.934 | |
| Kalvista Pharmaceuticals Inc | KalVista Pharmaceuticals, Inc. | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 1.400.061 $ | 0,87 | 52.105 | |
| Arrivent Biopharma Inc | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 1.379.192 $ | 0,85 | 45.563 | |
| Oculis Holding Ag | Oculis Holding AG | EC | H5870P102 | Long | Börsenkurs (Stufe 1) | 1.354.188 $ | 0,84 | 58.929 | |
| Maze Therapeutics Inc | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 1.312.469 $ | 0,81 | 49.602 | |
| Mannkind Corp | MannKind Corp. | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 1.197.269 $ | 0,74 | 317.578 | |
| Corvus Pharmaceuticals Inc | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 1.071.566 $ | 0,66 | 86.347 | |
| Olema Pharmaceuticals Inc | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 1.069.406 $ | 0,66 | 81.077 | |
| Zenas Biopharma Inc | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 1.018.109 $ | 0,63 | 55.332 | |
| Kura Oncology Inc | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 928.710 $ | 0,57 | 91.050 | |
| Ars Pharmaceuticals Inc | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 928.333 $ | 0,57 | 102.352 | |
| Xencor Inc | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 898.092 $ | 0,56 | 75.597 | |
| Theravance Biopharma Inc | Theravance Biopharma, Inc. | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 838.814 $ | 0,52 | 52.230 | |
| Geron Corp | Geron Corp. | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 825.311 $ | 0,51 | 660.249 | |
| Design Therapeutics Inc | Design Therapeutics, Inc. | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 666.193 $ | 0,41 | 63.568 | |
| Alto Neuroscience Inc | Alto Neuroscience, Inc. | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 642.742 $ | 0,40 | 32.025 | |
| Candel Therapeutics Inc | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 626.650 $ | 0,39 | 75.500 | |
| Tectonic Therapeutic Inc | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 603.136 $ | 0,37 | 19.353 | |
| Fulgent Genetics Inc | Fulgent Genetics, Inc. | EC | 359664109 | Long | Börsenkurs (Stufe 1) | 583.945 $ | 0,36 | 32.191 | |
| Rigel Pharmaceuticals Inc | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 580.591 $ | 0,36 | 19.042 | |
| Aclaris Therapeutics Inc | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 565.583 $ | 0,35 | 124.304 | |
| Upstream Bio Inc | Upstream Bio, Inc. | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 465.644 $ | 0,29 | 55.699 | |
| Neurogene Inc | Neurogene, Inc. | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 452.533 $ | 0,28 | 15.968 | |
| Compass Therapeutics Inc | Compass Therapeutics, Inc. | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 441.807 $ | 0,27 | 185.633 | |
| Altimmune Inc | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 408.932 $ | 0,25 | 134.076 | |
| Vanda Pharmaceuticals Inc | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 392.966 $ | 0,24 | 60.925 | |
| Delcath Systems Inc | Delcath Systems, Inc. | EC | 24661P807 | Long | Börsenkurs (Stufe 1) | 386.075 $ | 0,24 | 35.814 | |
| Atea Pharmaceuticals Inc | Atea Pharmaceuticals, Inc. | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 383.524 $ | 0,24 | 82.125 | |
| Zura Bio Ltd | Zura Bio, Ltd. | EC | G9TY5A101 | Long | Börsenkurs (Stufe 1) | 382.180 $ | 0,24 | 88.879 | |
| Regenxbio Inc | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 372.932 $ | 0,23 | 53.200 | |
| Rezolute Inc | Rezolute, Inc. | EC | 76200L309 | Long | Börsenkurs (Stufe 1) | 325.522 $ | 0,20 | 98.643 | |
| Anavex Life Sciences Corp | Anavex Life Sciences Corp. | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 289.432 $ | 0,18 | 95.522 | |
| Akebia Therapeutics Inc | Akebia Therapeutics, Inc. | EC | 00972D105 | Long | Börsenkurs (Stufe 1) | 281.643 $ | 0,17 | 276.121 | |
| Protara Therapeutics Inc | Protara Therapeutics, Inc. | EC | 74365U107 | Long | Börsenkurs (Stufe 1) | 259.228 $ | 0,16 | 55.748 | |
| Forte Biosciences Inc | Forte Biosciences, Inc. | EC | 34962G208 | Long | Börsenkurs (Stufe 1) | 246.232 $ | 0,15 | 12.912 | |
| Bicycle Therapeutics Plc | Bicycle Therapeutics PLC | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 241.301 $ | 0,15 | 51.450 | |
| Arcturus Therapeutics Holdings Inc | Arcturus Therapeutics Holdings, Inc. | EC | 03969T109 | Long | Börsenkurs (Stufe 1) | 231.969 $ | 0,14 | 29.289 | |
| Aardvark Therapeutics Inc | Aardvark Therapeutics, Inc. | EC | 002942100 | Long | Börsenkurs (Stufe 1) | 92.224 $ | 0,06 | 22.439 | |
| 161.845.033 $ | 100,03 | 7.757.973 |